My reviews
Selected research
-
Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticity.
bioRxiv : the preprint server for biology
-
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
-
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Clinical trials
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Partic...
PFS is defined as the time from randomization to the first occurrence of disease progression, as determined by blinded independent central review (BICR) according to RECIST v1.1, or death from any cause (whichever occurs first)
Recruiting
4.9